7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1184 | Rivaroxaban | BAY 59-7939 | Factor Xa , Thrombin |
Rivaroxaban (BAY 59-7939) is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both ... | |||
T67853 | Rivaroxaban Impurity | Rivaroxaban-10 | Factor Xa |
Rivaroxaban Impurity (Rivaroxaban-10) is a potent Blood-coagulation factor Xa inhibitor, IC50= 66 nM. | |||
T10174 | 5-R-Rivaroxaban | Factor Xa | |
5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban. Rivaroxaban (BAY 59-7939) is a highly potent and selective, direct Factor Xa (FXa) inhibitor (IC50 0.7 nM; Ki 0.4 nM). | |||
T78215 | Dechloro Rivaroxaban | Factor Xa , Others | |
Dechloro Rivaroxaban is an orally active and highly selective Factor Xa inhibitor.Dechloro Rivaroxaban has a significant inhibitory effect on free FXa in humans.Dechloro Rivaroxaban also has an inhibitory effect on throm... | |||
T12736 | Rivaroxaban-d4 | BAY 59-7939 D4 | Factor Xa |
Rivaroxaban D4 is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct inhibitor of Factor Xa (FXa)(IC50:0.7 nM; Ki:0.4 nM). | |||
T71096 | GCC-4401C methanesulfonate | ||
GCC-4401C methanesulfonate is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). | |||
T71362 | GCC-4401C free base | ||
GCC-4401C free base is a factor Xa inhibitor similar to rivaroxaban that is currently under development for venous thromboembolic disease (VTE). |